Format

Send to

Choose Destination
J Control Release. 2016 Oct 28;240:434-442. doi: 10.1016/j.jconrel.2016.02.034. Epub 2016 Feb 27.

AAV viral vector delivery to the brain by shape-conforming MR-guided infusions.

Author information

1
Interventional Neuro Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94110, USA. Electronic address: Krystof.Bankiewicz@ucsf.edu.
2
Interventional Neuro Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94110, USA.

Abstract

Gene transfer technology offers great promise as a potential therapeutic approach to the brain but has to be viewed as a very complex technology. Success of ongoing clinical gene therapy trials depends on many factors such as selection of the correct genetic and anatomical target in the brain. In addition, selection of the viral vector capable of transfer of therapeutic gene into target cells, along with long-term expression that avoids immunotoxicity has to be established. As with any drug development strategy, delivery of gene therapy has to be consistent and predictable in each study subject. Failed drug and vector delivery will lead to failed clinical trials. In this article, we describe our experience with AAV viral vector delivery system, that allows us to optimize and monitor in real time viral vector administration into affected regions of the brain. In addition to discussing MRI-guided technology for administration of AAV vectors we have developed and now employ in current clinical trials, we also describe ways in which infusion cannula design and stereotactic trajectory may be used to maximize the anatomical coverage by using fluid backflow. This innovative approach enables more precise coverage by fitting the shape of the infusion to the shape of the anatomical target.

KEYWORDS:

Adeno-associated virus; Axonal transport; Brain delivery; Clinical trial; Gene therapy; MRI; Pre-clinical research; Shape fitting

PMID:
26924352
DOI:
10.1016/j.jconrel.2016.02.034
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center